Atlas Trials

Efficacy of Infusions of MSC From Wharton Jelly in the SARS-Cov-2 (COVID-19) Related Acute Respiratory Distress Syndrome

Clinical trial NCT04625738 · COMPLETED

Trial details

NCT number
NCT04625738
Sponsor
Central Hospital, Nancy, France
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
COVID19 ARDS
Start date
2020-11-06
Primary completion
2021-05-14
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.